AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.
AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways. — المؤلف: Chow, Raymond Kwok Kei — Oncotarget Oct 2017
- المؤلف
- Chow, Raymond Kwok Kei
- النشر
- Oncotarget Oct 2017
- الوصف
- 83469-83479 p.